How Does the Future of DNA Testing Tie into Heart Health?
The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.
The genetic testing industry is booming. Consumers want to trace their lineage, but there are more exciting applications since genes can point to health issues as well. Discussing the evolution of the field, I Don’t Care host Kevin Stevenson spoke with Alex Mulyar, CEO of CRI Genetics.
“We started in the genealogy route, building up databases, and then began to get into health-oriented reports for weight loss and allergies. Now, we’re looking at more clinical applications like cardiology,” Mulyar explained.
The question became how to apply genetic information to a person’s health. Mulyar spoke about his own results around caffeine consumption. “I received the report, and my metabolism was low but my anxiety gene high, and the recommendation was to drink no more than two cups and never after 2:00 pm.”
The next step for the company was to look at using genetic testing in clinical settings. “We did a lot of internal R&D to figure out how to create a tool doctors could use. It became a blueprint of how people metabolize medications or react to certain things.”
“Those with naturally high cholesterol that look healthy often don’t find this out until after their first heart attack. DNA testing can prevent this.” – Alex Mulyar
The company is now taking learnings to apply them to cardiology. For example, those with naturally high cholesterol can often be fit and healthy. However, they wouldn’t know this is their genetic predisposition until after their first heart attack. “Doctors can do a simple DNA test and understand this, so they can prescribe statins to prevent heart attacks,” Mulyar said.
Further, cardiologists can also use it to understand medication. “If a patient metabolizes medication slowly, they may have dosages building up, or for those metabolize too fast, it could be the opposite,” Mulyar added.
Listen to Previous Episodes of I Don’t Care!
Follow us on social media for the latest updates in B2B!
Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale
Latest
Mastering AV Sales Strategies: A Diverse Market Requires Understanding Individual Needs
Mastering AV sales strategies in a global professional audio-visual (Pro AV) market, poised to reach $79.2 billion by 2028, requires much attention to detail. The surge in demand from corporate, government, and institutional sectors, driven by the need for enhanced productivity and efficient working environments, gives AV sales pros a lot of opportunity. In […]
Cybersecurity in Healthcare: Addressing the Growing Threat
To keep up with the growing threats, cybersecurity in healthcare is a high-level priority. The recent ransomware attack on Ardent Health underscores a stark reality for the healthcare industry: cyber threats are a significant and ongoing challenge. Mike Saylor, the CEO of Blackswan Cybersecurity, LLC, sheds light on the complexities of cybersecurity in healthcare. […]
Effective Debt Management Holds the Keys to Small Business Cash Flow and Growth
Effective debt management through a robust accounts receivable system is essential for small business cash flow and growth, necessitating automated payment schedules and strategic policy adjustments. Collaborating with a collection agency as a strategic partner can enhance revenue recovery while preserving positive customer relationships. How critical is effective debt management for the financial health […]
